On the tremendous success of 1st &2nd conferences on Dementia, we are announccing "3rd Innovations and state of the Art In Alzheimer's & Dementia Research" which will take place in the gorgeous city of London, UK during July18-20, 2019.
A special invitation is extended to international colleagues to attend and contribute to the conference. Mark your calendars now and for more details please contact us at email@example.com
3rd Innovations and State of the Art In Alzheimer’s & Dementia Research (ISAADR-2019)
On the successful of our previous year conferences, Innovinc International welcomes you to attend the ISAADR-2019 during July 18 - 20, 2019 at London, UK.
Alzheimer’s & Dementia Research -2019 anticipates more than 200 participants around the globe with thought provoking Keynote lectures, Oral and Poster presentations. This is an excellent opportunity for the delegates from Universities and Institutes to interact with the world class Neurologists, Psychiatrist, Neuroscientists, Nutritional Scientists, Neurosurgeons, Healthcare clinicians, Researchers.
This International ISAADR-2019 conference brings together researchers, educators and practitioners representing research and educational institutions, hospitals, associations and consulting organizations from all over the world to exchange ideas, to define the research priorities in the fields of Alzheimer’s & Dementia Research.DOWNLOAD BROCHURE
We invite you to submit your abstract in relation to research and proficiency in Alzheimer’s & Dementia. Abstracts of all the related interest areas are accepted, but are not limited to the following sessions:
Innovinc International welcomes you to attend the 3rd Innovations and state of the Art In Alzheimer's & Dementia Reserach during July 18 - 20, 2019,at London, UK. To meet renowned speakers, world's leading CEO's, Directors, decision and policy makers.
To know about the ongoing research projects on Alzheimer's & Dementia and to share the research ideas and implement them in Alzheimer's & Dementia. New contacts to enhance the business opportunities. Engage with high profile international and national speakers
VIEW ALL SPEAKERS
Thu , Jul 18, 2019
Title: Omental Transposition to the Brain for Alzheimer’s Disease
Harry S. Goldsmith, Emeritus professor, United States
Title: The Utility Of Polygenic Risk Scores To Identify Individuals For Risk Of Cognitive Decline And Alzheimer’s Disease: New Opportunities For Clinical Trial Design
Richard Pither, Cytox Ltd, united kingdom
Title: Development of skin biomarkers as a rapid and least invasive diagnostic test for Alzheimer’s and other neurodegenerative diseases
Wenquan Zou, Case Western Reserve University School of Medicine, USA
Title: Atypical presentation of Alzheimer’s disease – diagnosis and management
Chuang-Kuo Wu, University of California - Irvine School of Medicine, United States
Title: Synaptic dysfunction in dementia: JNK’s role
Tiziana Borsello, Università degli Studi di Milano, Italy
Title: Structural effects of phosphorylation and the R406W mutation on tau
Neal Zondlo, University of Delaware, United States
Title: Transcranial Magnetic Stimulation markers represent an innovative approach for the diagnosis of Prodromal Alzheimer Disease
Alessandro Padovani, University of Brescia, Italy
Title: Fenamates and Dementia: Gene therapy in a Pill
Nasser H. Zawia, University of Rhode Island, USA
Title: Putative diet and lifestyle risk factors in Dementia and cognitive impairment
Douglas Wardell Wilson, Formerly Durham (UK) and Swansea (Wales), United Kingdom
Title:Comparison of cholinergic status with quantitative EEG in healthy subjects and patients suspected of dementia.
Rolf Ekedahl, NeuFydi, Sweden
Title: Antidepressants, AKA1 and AKA5, increase -amyloid deposition in APPswe/PSEN1dE9 transgenic mice
Shing-Chuan Shen, Taipei Medical University, Taiwan
Title: TREM2: Ramifications for hiPSC-Microglial functionality in AD
Jennifer Pocock, Queen Square Institute of Neurology, United Kingdom
Title: Neurotrophic factor a-1 gene mutation in AD patient leads to dementia and depression in mice
Loh, Y Peng, National Institutes of Health, USA
Title: Cognitive Design based research on Dimentia
Suraj Kumar, National Institute of Design, India
Title: The impact of virtual memory palaces on well-being with dementia
Kasper Bormans, University of Leuven, Belgium
Title: Pioglitazone Reduces Dementia Risk in Patients with Type 2 Diabetes Mellitus: A Retrospective Cohort Analysis
Chin-Hsiao Tseng, National Taiwan University Hospital, Taiwan
This is the tentative program and Program schedule is subjected to change with final allotment of speaker slots
Fri , Jul 19, 2019
Title: Development of iCrystal System for Rapid Crystallization of the Amyloid Precursor Protein
Jayfus Tucker Doswell, The Juxtopia Group, USA
Keynote Slot Available
Keynote Slot Available
Title: Mechanistic approach to higher rate of AD among Arctic populations: activation of brain inflammatory pathways by elevated 2,3,7,8-TCDD body burdens.
Ilya B. Tsyrlov, Xenotox. Inc, United States
Title: Novel biologics reverse cognitive function deficits and amyloid plaques in Alzheimer’s disease animal models.
Mourad Tayebi, Western Sydney University, Australia
Title: DNA Polymerase as Therapeutic Intervention for Treating Patients with Multiple Sclerosis.
Sherif Salah Abdelaziz Hesen, Cairo University, Egypt
Title: Silicic acid and beer consumption reverses the metal imbalance and the prooxidant status induced by aluminum nitrate in mouse brain
Francisco José Sánchez Muniz, Complutense University, Spain
Title: Role of the whole-exome sequencing analysis in diagnosis of clinically heterogenous families with ataxia.
Marta Leńska-Mieciek, Centre of Postgraduate Medical Education, Warsaw, Poland
Title: Therapeutic Benefits of the Camelid-Derived Antibodies in a Human Induced Pluripotent Stem Cells Derived from an Alzheimer’s Disease Patient
Utpal Kumar Adhikari, Western Sydney University, Australia
Title: Alzheimer’s disease causative viruses HSV-1 and CMV are highly susceptible targets for bHLH/PAS dioxin receptor-Arnt transcription pathway in glial cells.
Ilya B. Tsyrlov, Xenotox. Inc, United States
Title: The Dementia Care in Hospitals Program – A National Program to improve hospital care for patients with cognitive impairment.
Mark Yates, Deakin University, Australia
Title: APOE4 Polymorphism and The Pattern of FTIR Spectra in Patients with Alzheimer’s disease
Sarawut Suksuphew, Suranaree University of Technology, Thailand
Title: Crucial role of mitofilin and cyclophilin D interaction in post-ischemic GPER1-induced protection against ischemia-reperfusion injury.
Jean C Bopassa, University of Texas Health Science San Antonio School of Medicine, USA
Title: Regulatory Mechanism of miR-543-3p on GLT‑1 in a Mouse Model of Parkinson’s Disease
Shaogang Qu, Shunde Hospital, Southern Medical University, China
Title: Optical detection of Alzheimer’s disease in mice with single domain antibody fragments.
Umma Habiba, Western Sydney University, Australia
Title: Interaction between Herpes Simplex Virus type 1 and APOE4 in the onset of Alzheimer’s disease in the Three-City prospective cohort study
Linard Morgane, Inserm Bordeaux Population Health, France
Title: Antidepressants, AKA1 and AKA5, induced intestinal microbial dysbiosis is associated with increased risk of Alzheimer’s disease
Ming-Hsuan Liao, Taipei Medical University, Taiwan
Spekaer slots are available
Sat , Jul 20, 2019
Tue , Oct 15, 2019
We will update soon.....
Don t Miss This Amazing Conference And Opportunities